Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
I think the issue is more complex than is admitted in the editorial. For example,

...there are strong arguments against sharing raw data routinely. Raw data sets are large and complex, include potentially sensitive individual participant data, and are not needed for most secondary analyses of shared clinical trial data.

More comprehensive discussion.

by asdf on Fri Jan 21st, 2022 at 03:13:39 PM EST
[ Parent ]

Others have rated this comment as follows:


Top Diaries

Occasional Series